Medical/Pharmaceuticals

CanSinoBIO Announces Approval for its Single-Dose COVID-19 Vaccine Convidecia™ in Chile

* Marks vaccine's first approval in South America, following Mexico, Pakistan, China and Hungary * Safe, stable storage and transportation between 2°C and 8°C, accessible by under-developed regions * 95.47% effective overall in preventing severe COVID-19 diseases 14 days after vaccination TI...

2021-04-08 21:17 7025

Lunit will participate in a Groundbreaking Prospective Study to Validate AI Performance

* A research team at the Karolinska Institutet in Sweden will assess the performance of AI startup Lunit's breast cancer AI software as an independent mammography reader in screening * The prospective study marks first of its kind, aiming to screen 55,000 women with mammography at Capio Sankt...

2021-04-08 16:15 2046

SenseTime Receives CE Mark for its AI Medical Solution SenseCare- Chest DR Pro Diagnostic Software

HONG KONG, April 8, 2021 /PRNewswire/ -- SenseTime, the world-leading artificial intelligence (AI) company, announced that it has recently been granted CE mark approval for its AI medical solution SenseCare-Chest DR Pro. Leveraging SenseTime's cutting-edge AI technologies, the solution can quickl...

2021-04-08 15:00 2487

SenseTime Receives CE Mark for its AI Medical Solution SenseCare- Chest DR Pro Diagnostic Software

SINGAPORE, April 8, 2021 /PRNewswire/ -- SenseTime, the world-leading artificial intelligence (AI) company, announced that it has recently been granted CE mark approval for its AI medical solution SenseCare-Chest DR Pro. Leveraging SenseTime's cutting-edge AI technologies, the solution can quickl...

2021-04-08 15:00 1940

SenseTime Receives CE Mark for its AI Medical Solution SenseCare-Chest DR Pro Diagnostic Software

KUALA LUMPUR, Malaysia, April 8, 2021 /PRNewswire/ -- SenseTime, the world-leading artificial intelligence (AI) company, announced that it has recently been granted CE mark approval for its AI medical solution SenseCare-Chest DR Pro. Leveraging SenseTime's cutting-edge AI technologies, the solut...

2021-04-08 15:00 2444

SenseTime Receives CE Mark for its AI Medical Solution SenseCare-Chest DR Pro Diagnostic Software

BANGKOK, April 8, 2021 /PRNewswire/ -- SenseTime, the world-leading artificial intelligence (AI) company, announced that it has recently been granted CE mark approval for its AI medical solution SenseCare-Chest DR Pro. Leveraging SenseTime's cutting-edge AI technologies, the solution can quickly ...

2021-04-08 15:00 2218

EyeYon Medical Announces Innovative Medical Device Designation Granted For EndoArt® In China

TEL-AVIV, Israel, April 8, 2021 /PRNewswire/ -- EyeYon Medical, an Israeli start-up company developing a variety of ophthalmic products for vision-threatening conditions, announces today that EndoArt® was granted the Innovative Device Status byChina's Center for Medical Device Evaluation, the ar...

2021-04-08 08:00 2363

Inmagene R&D Team expands with two new senior members joining the Company

SAN DIEGO and SHANGHAI and HANGZHOU, China, April 7, 2021 /PRNewswire/ -- Inmagene Biopharmaceuticals ("Inmagene") today announced that Dr.Anbo Xiang and Dr.Qian Xu joined the company. As CMO (China) and Senior VP, Operations, Dr. Xiang will be responsible for clinical development, operations, an...

2021-04-07 09:00 16923

WuXi Biologics Successfully Completed Pre-License Inspection and Routine GMP Inspection by U.S. FDA

WUXI, China, April 7, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, today announced that it has successfully completed both a Pre-License Inspection (PLI) and a routine GMP inspection by the U.S. FDA (FDA). T...

2021-04-07 08:22 22077

EDDA Technology Announces US$150 Million Financing Round, led by Softbank Vision Fund 2, with OrbiMed Participation, to Advance Intelligent Robotic Solutions for Precision Surgery

SHANGHAI and SUZHOU, China, April 7, 2021 /PRNewswire/ -- EDDA Healthcare and Technology Holding Ltd. and its subsidiaries EDDA Technology (Shanghai) Ltd., EDDA Technology Medical Solutions (Suzhou) Ltd., and EDDA Technology, Inc ( Princeton, NJ, USA), (hereafter jointly referred to as EDDA Techno...

2021-04-07 07:00 38547

Shanghai Genechem Co., Ltd. (Genechem) Announces Global Collaboration on Bispecific Antibodies

SHANGHAI, April 6,, 2021 /PRNewswire/ -- Shanghai Genechem Co., Ltd. (Genechem), a discovery company dedicated to novel drug target discovery and development of novel therapeutics, today announced the execution of a global collaboration with I-Mab (Nasdaq: IMAB), a Nasdaq-listed global bioph...

2021-04-06 22:26 37922

Gan & Lee receives EMA orphan drug designation for Phase I drug candidate GLR2007 for the treatment of glioma

BEIJING, and BRIDGEWATER, N.J., April 6, 2021 /PRNewswire/ -- Gan & Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan & Lee, stock code: 603087.SH), a global biopharmaceutical company, today announced that the European Medicine Agency (EMA) Committee for Orphan Medicinal Products ...

2021-04-06 20:53 3192

Smart Glove Acclaimed by Frost & Sullivan for Introducing Several First-of-their-kind Medical Gloves to the Market

Smart Glove is a global leading supplier of nitrile, latex, vinyl, and other synthetic gloves for industries ranging from healthcare to food and beverage KUALA LUMPUR, Malaysia, April 6, 2021 /PRNewswire/ -- Based on its recent analysis of the global medical gloves market, Frost & Sullivan recogn...

2021-04-06 16:23 1905

How to Power Your Hospital with Artificial Intelligence in Medical Imaging

Frost & Sullivan's white paper highlights the process of creating an AI strategy for your imaging department SANTA CLARA, Calif., April 6, 2021 /PRNewswire/ -- The medical imaging industry is in the midst of large-scale transformation, largely driven by the advancements in technologies such as a...

2021-04-06 14:02 2845

Review of Myopia Management and Plano Announce New Content Partnership

SINGAPORE, April 6, 2021 /PRNewswire/ -- Review of Myopia Management  (RMM) is pleased to announce a new partnership with theSingapore-based Healthtech company, Plano Pte Ltd . Under their new agreement,RMM and Plano will produce new educational con...

2021-04-06 11:00 4823

Antengene Announces NMPA Approval of IND Application for ATG-019 in Patients with Advanced Solid Tumors or Non-Hodgkin's Lymphoma

SHANGHAI and HONG KONG, April 6, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in class therapeutics in hematology and oncol...

2021-04-06 08:00 7990

Novavax Initiates COVID-19 Vaccine Clinical Trial Crossover

* Crossover allows participants to continue in trials and remain blinded * Ensures that all trial participants receive active vaccine * South Africa and UK crossover arms initiated; US/Mexico PREVENT-19 crossover planned GAITHERSBURG, Md., April 6, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq:...

2021-04-06 05:00 5942

AI-Based Imaging Analysis Tools and Cloud-Based Deployments to Bolster the Global Digital Pathology Market

SANTA CLARA, Calif., April 5, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis, AI-Based Image Analysis Tools and Cloud-Based Deployment to Expand the Global Digital Pathology Market, finds that this market is estimated to hit $825.9 million by 2025 from $513.3 million in 2019 at a compoun...

2021-04-05 18:03 3271

Pfizer collaborates with DoctorOnCall to improve health literacy and patient care in Malaysia

KUALA LUMPUR, Malaysia, April 5, 2021 /PRNewswire/ -- Pfizer today announced its collaboration with DoctorOnCall to launch a digital therapeutics platform that focuses on three key therapeutic areas namely smoking cessation, vaccination, and heart health. Catering to an increasingly tech-savvy an...

2021-04-05 11:32 19727

Ascentage Pharma Appoints Renowned Oncologist Dr. David Sidransky, MD, to its Board as an Independent Non-Executive Director

SUZHOU, China and ROCKVILLE, Md., April 2, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced its appointment of Dr.David ...

2021-04-02 19:39 4809
1 ... 252253254255256257258 ... 382